tech_banner
Adipogen/Nargenicin A<sub>1</sub>/BVT-0204-M001/1 mg
More Information Product Details Synonyms Product Type Properties Formula MW CAS Source/Host Chemicals Purity Chemicals Appearance Solubility Identity Declaration InChi Key Shipping and Handling Shipping Short Term Storage Long Term Storage Use/Stability Documents MSDS Product Specification Sheet Datasheet
CP-47,444; CS682
Chemical
C28H37NO8
515.6
70695-02-2
Isolated from Actinomyces sp. Gö301.
≥98% (HPLC)
Off-white powder.
Soluble in DMSO or methanol.
Determined by 1H-NMR.
Manufactured by BioViotica.
YEUSSARNQQYBKH-SIMZXIQRSA-N
AMBIENT
+4°C
-20°C
Stable for at least 1 year after receipt when stored at -20°C.After reconstitution protect from light at -20°C.
Download PDF
Download PDF
  • Antibiotic against Gram-positive bacteria, particularly Staphylococcus and Clostridia.
  • More effective against multi-resistant strains (MRSA) than erythromycin and vancomycin.
  • Inhibits cell proliferation and induces HL-60 cell differentiation in combination with 1,25-Dihydroxyvitamin-D3 and ATRA.
  • Displays low cytotoxicity compared to erythromycin and spiramycin.
Product References
  • Structure of natural antibiotic CP-47,444: W.D. Celmer et al., J. Am. Chem. Soc. 102, 4203-4209 (1980).
  • 9-O-Esters of nodusmicin: B.J. Magerlein and S.A. Mizsak, J. Antibiot. 35, 111-112 (1981).
  • Biosynthetic origin of the carbon skeleton and oxygen atoms of nargenicin A1: D.E. Cane and C. Yang, J. Am. Chem. Soc. 106, 784-787 (1984).
  • Biosynthesis of nargenicin and nodusmicin: W.C. Snyder and K.L. Rinehart, jr., J. Am. Chem. Soc. 106, 787-789 (1984).
  • Nargenicin biosynthesis: D.E. Cane et al., J. Am. Chem. Soc. 115, 527-535 (1993).
  • The chemistry of the Nargenicin macrolides: J. Kallmerten, in Studies in natural products chemistry (Ed.: A.-U. Rahman, Elsevier)17, 283-310 (1995).
  • Production, isolation and biological activity of nargenicin from Nocardia sp. CS682: J.K. Sohng et al., Arch. Pharm. Res. 31, 1339-1345 (2008).
  • Quantitative analysis of nargenicin in Nocardia sp. CS682 culture by HPLC: S.S. Cho et al., Arch. Pharm. Res. 32, 335-340 (2009).
  • Nargenicin attenuates lipopolysaccharide-induced responses in BV-2 cells: J.C. Yoo et al., Neuroreport 20, 1007 (2009).
  • Nargenicin enhances 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced leukemia cell differentiation via PKCbetal/MAPK pathways: S.H. Kim et al., Biochemical Pharmacology 77, 1694-1701 (2009).